Zelante, Teresa
University of Perugia
9 papers on CoChatORCID 0000-0002-7071-0302
Most cited papers
- Verified
Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22
Zelante, T., Iannitti, R. G., Cunha, C., De Luca, A., Giovannini, G., Pieraccini, G., Zecchi, R., D’Angelo, C., Massi-Benedetti, C., Fallarino, F., et al. (2013) · Immunity
Gut microbiota and healthTryptophan and brain disorders
Cited by 2,614
- Verified
Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease
Romani, L., Fallarino, F., De Luca, A., Montagnoli, C., D’Angelo, C., Zelante, T., Vacca, C., Bistoni, F., Fioretti, M. C., Grohmann, U., et al. (2008) · Nature
Neutrophil, Myeloperoxidase and Oxidative MechanismsTryptophan and brain disorders
Cited by 535
- Verified
Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity
Cunha, C., Di Ianni, M., Bozza, S., Giovannini, G., Zagarella, S., Zelante, T., D'Angelo, C., Pierini, A., Pitzurra, L., Falzetti, F., et al. (2010) · Blood
Antifungal resistance and susceptibilityImmunodeficiency and Autoimmune Disorders
Cited by 286
- Verified
IL-22 defines a novel immune pathway of antifungal resistance
De Luca, A., Zelante, T., D'Angelo, C., Zagarella, S., Fallarino, F., Spreca, A., Iannitti, R. G., Bonifazi, P., Renauld, J.-C., Bistoni, F., et al. (2010) · Mucosal Immunology
Antifungal resistance and susceptibilityPsoriasis: Treatment and Pathogenesis
Cited by 265
- Verified
Role of complement and Fcγ receptors in the protective activity of the long pentraxin PTX3 against Aspergillus fumigatus
Moalli, F., Doni, A., Deban, L., Zelante, T., Zagarella, S., Bottazzi, B., Romani, L., Mantovani, A., & Garlanda, C. (2010) · Blood
Biomarkers in Disease MechanismsComplement system in diseases
Cited by 205
- Verified
Immunotherapeutic approaches to treatment of fungal diseases
Armstrong-James, D., Brown, G. D., Netea, M. G., Zelante, T., Gresnigt, M. S., van de Veerdonk, F. L., & Levitz, S. M. (2017) · The Lancet Infectious Diseases
Antifungal resistance and susceptibilityFungal Infections and Studies
Cited by 135
- Verified
CD103+ Dendritic Cells Control Th17 Cell Function in the Lung
Zelante, T., Wong, A. Y. W., Ping, T. J., Chen, J., Sumatoh, H. R., Viganò, E., Hong Bing, Y., Lee, B., Zolezzi, F., Fric, J., et al. (2015) · Cell Reports
Psoriasis: Treatment and PathogenesisT-cell and B-cell Immunology
Cited by 90
- Verified
The cross-talk between opportunistic fungi and the mammalian host via microbiota’s metabolism
Romani, L., Zelante, T., Palmieri, M., Napolioni, V., Picciolini, M., Velardi, A., Aversa, F., & Puccetti, P. (2015) · Seminars in Immunopathology
Gut microbiota and healthAntifungal resistance and susceptibility
Cited by 47
- Verified
Impaired calcineurin signaling in myeloid cells results in downregulation of pentraxin-3 and increased susceptibility to aspergillosis
Zelante, T., Wong, A. Y. W., Mencarelli, A., Foo, S., Zolezzi, F., Lee, B., Poidinger, M., Ricciardi-Castagnoli, P., & Fric, J. (2017) · Mucosal Immunology
Antifungal resistance and susceptibilitySignaling Pathways in Disease
Cited by 32
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free